Chitosan as Potential Marine Nutraceutical

Advances in Food and Nutrition Research

Volumn 65, Issue , 2012, Pages 121-135

  Je, Jae Young ^a   Kim, Se Kwon ^b  

^a Chonnam National University   (South Korea)

^b Pukyong National University   (South Korea)

Author keywords

Anti inflammatory; Antimicrobial; Antioxidant; Biological activities; Chitosan; Hypocholesterolemic

Indexed keywords

EID: 84863156560     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-416003-3.00007-X     Document Type: Chapter

References (71)

1. Aiba S. Studies on chitosan: 2. Solution stability and reactivity of partially N-acetylated chitosan derivatives in aqueous media. Int. J. Biol. Macromol. 1989, 11:249-252.
2. Alasalvar C., Shahidi F., Quantick P. Food and health applications of marine nutraceuticals: A review. Seafoods: Quality, Technology, and Nutraceutical Applications 2002, 175-204. Springer-Verlag, Berlin. C. Alasalvar, T. Taylor (Eds.).
3. Allan G.R., Hadwiger L.A. The fungicidal effect of chitosan on fungi of varying cell wall composition. Exp. Mycol. 1979, 3:285-287.
4. Anandan R., Mathew S., Viswanathan N.P.G. Antiulcerogenic effects of chitin and chitosan on mucosal antioxidant defense system in HCl-ethanol induced ulcer in rats. J. Pharm. Pharmacol. 2004, 56:265-269.
5. Anraku M., Fujii T., Furutani N., Kadowaki D., Maruyama T., Otagiri M., Gebiciki J.M., Tomida H. Antioxidant effects of a dietary supplement: Reduction of indices of oxidative stress in normal subjects by water-soluble chitosan. Food Chem. Toxicol. 2009, 47:104-109.
6. Anraku M., Fujii T., Kono T., Kojima E., Hata T., Tabuchi N., Tsuchiya D., Goromaru T., Tsutsumi H., Kadowaki D., Maruyama T., Otagiri M., et al. Antioxidant properties of high molecular weight dietary chitosan in vitro and in vivo. Carbohydr. Polym. 2011, 83:501-505.
7. Bokura H., Kobayashi S. Chitosan decreases total cholesterol in women. A randomized, double-blind, placebo-controlled trial. Eur. J. Clin. Nutr. 2003, 57:721-725.
8. Boon N.A., Aronson J.K. Dietary salt and hypertension: Treatment and prevention. Br. Med. J. 1985, 290:949-950.
9. Chang H.Y., Chen J.J., Fang F., Chen Z. Enhancement of antibody response by chitosan, a novel adjuvant of inactivated influenza vaccine. Chin. J. Biol. 2004, 17:21-24.
10. Chatterjee S., Adhya M., Guha A.K., Chatterjee B.P. Chitosan from Mucor rouxii: Production and physico-chemical characterization. Process Biochem. 2005, 40:395-400.
11. Chou T.C., Fu E., Shen E.C. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 2003, 308:403-407.
12. Crestini C., Kovac B., Sermanni G.G. Production and isolation of chitosan from submerged and solid state fermentation from Lentinus edodes. Biotechnol. Bioeng. 1996, 50:207-210.
13. Drayton D.L., Liao S., Mounzer R.H., Ruddle N.H. Lymphoid organ development: From ontogeny to neogenesis. Nat. Immunol. 2006, 7:344-353.
14. Futaki N., Tajahashi S., Kitagawa T., Yamakawa Y., Tanka M., Higuchi S. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo. Inflamm. Res. 1997, 46:496-502.
15. Guslandi M. Nitric oxide and inflammatory bowel diseases. Eur. J. Clin. Invest. 1998, 28:904-907.
16. Hall G., Lund L., Lamb J.R., Jarman E.R. Kinetics and mode of peptide delivery via the respiratory mucosa determine the outcome of activation versus TH2 immunity in allergic inflammation of the airways. J. Allergy Clin. Immunol. 2002, 110:883-890.
17. Hammond R.A., Hannon R., Frean S.P., Armstrong S.J., Flower R.J., Bryant C.E. Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. Am. J. Vet. Res. 1999, 60:426-431.
18. Hirano S., Nagao N. Effects of chitosan, pectic acid, lysozyme and chitinase on the growth of several phytopathogens. Agric. Biol. Chem. 1989, 53:3065-3066.
19. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 1998, 15:1326-1331.
20. Imonek J., Bartonova H. Effect of dietary chitin and chitosan on cholesterolemia of rats. Acta Vet. Brno 2005, 74:491-499.
21. Jeon Y.J., Kim S.K. Production of chitooligosaccharides using an ultrafiltration membrane reactor and their antibacterial activity. Carbohydr. Polym. 2000, 41:133-141.
22. Jeon Y.J., Kim S.K. Potential immuno-stimulating effect of antitumoral fraction of chitosan oligosaccharides. J. Chitin Chitosan 2001, 6:163-167.
23. Jeon Y.J., Park P.J., Kim S.K. Antimicrobial effect of chitooligosaccharides produced by bioreactor. Carbohydr. Polym. 2001, 44:71-76.
24. KFDA Food Additives Code 1995, Korea Food and Drug Administration, Seoul, p. 449.
25. Kim M.S., Sung M.J., Seo S.B., Yoo S.J., Lim W.K., Kim H.M. Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid β peptide and interleukin-1β. Neurosci. Lett. 2002, 321:105-109.
26. Kim M.S., You H.J., You M.K., Kim N.S., Shim B.S., Kim H.M. Inhibitory effect of water-soluble chitosan on TNF-α and IL-8 secretion from HMC-1 cells. Immunopharmacol. Immunotoxicol. 2004, 26:401-409.
27. Knorr D. Use of chitinous polymers in food-a challenge for food research and development. Food Technol. 1984, 38:85-97.
28. Kurita K. Chitin and chitosan: Functional biopolymers from marine crustaceans. Mar. Biotechnol. 2006, 8:203-226.
29. Lee J.K., Kim S.U., Kim J.H. Modification of chitosan to improve its hypocholesterolemic capacity. Biosci. Biotechnol. Biochem. 1999, 63(5):833-839.
30. Lee S.J., Kim E.K., Moon S.H., Jeon B.T., Park P.J., Song M.D. Antimicrobial activity of β-chitosan against VRSA and MRSA. J. Chitin Chitosan 2009, 14:130-133.
31. Lengsfeld H., Fleury A., Nolte M., Piquerez J.C., Hadvary P., Beglinger C. Effect of orlistat and chitosan on faecal fat excretion in young healthy volunteers. Obes. Res. 1999, 7(Suppl. 1):50S.
32. Li L., Zhang J.L., Liu J.N., Xia W.S. Effects of chitosan on serum lipid and fat liver. Chin. J. Mar. Drugs 2007, 26:7-9.
33. Lim S.H., Hudson S.M. Review of chitosan and its derivatives as antimicrobial agents and their uses as textile chemicals. J. Macromol. Sci. 2003, 43:223-269.
34. Liu J.N., Xia W.S., Zhang J.L. Effects of chitosans physico-chemical properties on binding capacities of lipid and bile salts in vitro. Chin. Food Sci. 2008, 29:45-49.
35. Liu J.N., Zhang J.L., Xia W.S. Hypocholesterolemic effects of different chitosan samples in vitro and in vivo. Food Chem. 2008, 107:419-425.
36. Mark Strong V.E., Mackrell P.J., Concannon E.M., Mestre J.R., Smyth G.P., Schaefr P.A., Stapleton P.P., Daly J.M. NS-398 treatment after trauma modifies NF-kappa B activation and improves survival. J. Surg. Res. 2001, 98:40-46.
37. Moskovitz L., Yim M.B., Chock P.B. Free radicals and disease. Arch. Biochem. Biophys. 2002, 397:354-359.
38. Muzzarelli R. In vivo biochemical significance of chitin-based medical items. Polymeric Biomaterials 1994, 179-197. Marcel Dekker, New York. S. Dumitriu (Ed.).
39. Nagyvary J.J., Falk J.D., Hill M.L., Schmidt M.L., Wilkins A.K., Bradbury E.L. The hypolipidemic activity of chitosan and other polysaccharides in rats. Nutr. Rep. Int. 1979, 20:677-684.
40. Nishimura K., Nishimura S., Nishi N., Saiki I., Tokura S., Azuma I. Immunological activity of chitin and its derivatives. Vaccine 1984, 2:93-99.
41. No H.K., Park N.Y., Lee S.H., Meyers S.P. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int. J. Food Microbiol. 2002, 74:65-72.
42. Okuda H., Kato H., Tsujita T. Antihypertensive and antihyperlipidemic actions of chitosan. J. Chitin Chitosan 1997, 2:49-59.
43. Park P.J., Jung W.K., Nam K.S., Shahidi F., Kim S.K. Purification and characterization of antioxidative peptides from protein hydrolysate of lecithin-free egg yolk. J. Am. Oil Chem. Soc. 2001, 78:651-656.
44. Park P.J., Je J.Y., Kim S.K. Free radical scavenging activities of differently deacetylated chitosans using an ESR spectrometer. Carbohydr. Polym. 2004, 55:17-22.
45. Park P.J., Je J.Y., Byun H.G., Moon S.H., Kim S.K. Antimicrobial activity of hetero-chitosans and their oligosaccharides with different molecular weights. J. Microbiol. Biotechnol. 2004, 14:317-323.
46. Park J.K., Moon H.R., Kim W.J., Kim S.M., Park Y.I. Preparation and antimicrobial activity of medium-molecular weight chitosan. J. Chitin Chitosan 2009, 14:138-142.
47. Rane K.D., Hoover D.G. Production of chitosan by fungi. Food Biotechnol. 1993, 7:11-33.
48. Rasmussen R.S., Morrissey M.T. Chitin and chitosan. Marine Nutraceuticals and Functional Foods 2007, 155-182. CRC Press, New York. F. Shahidi, C. Barrow (Eds.).
49. Ritchlin C.T., Haas-Smith S.A., Li P., Hicks D.G., Schwarz E.M. Mechanisms of TNF-α and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 2003, 111:821-831.
50. Seo H., Mitsuhashi K., Tanibe H. Antibacterial and antifungal fiber blended by chitosan. Advances in Chitin and Chitosan 1992, 34-40. Elsevier Applied Science, London and New York. C.J. Brine, P.A. Sanford, J.P. Zikakis (Eds.).
51. Shibasaki K., Sano H., Matsukubo T., Takaesu Y. Effects of low molecular chitosan and pH changes in human dental plague. Bull. Tokyo Dent. Coll. 1994, 35:33-39.
52. Simons R.K., Junger W.G., Loomis W.H., Hoyt D.B. Acute lung injury in endotoxemic rats is associated with sustained circulating IL-6 levels and intrapulmonary CINC activity and neutrophil recruitment-role of circulating TNF-α and IL-β?. Shock 1996, 6:39-45.
53. Sugano M., Fujikawa T., Hiratsuji Y., Hasegawa Y. Hypocholesterolemic effects of chitosan in cholesterol-fed rats. Nutr. Rep. Int. 1978, 18:531-537.
54. Sugano M., Fujikawa T., Hiratsuji Y., Nakashima K., Fukuda N., Hasegawa Y. A novel use of chitosan as a hypocholesterolemic agent in rat. Am. J. Clin. Nutr. 1980, 33:787-793.
55. Sugano M., Watanabe S., Kishi A., Izumi M., Ohtakara A. Hypocholesterolemic action of chitosans with different viscosity in rats. Lipids 1988, 23:187-191.
56. Sugano M., Yoshida K., Hashimoto H., Enomoto K., Hirano S. Hypocholesterolemic activity of partially hydrolyzed chitosan in rats. Advances in Chitin and Chitosan 1992, 472-478. Elsevier Applied Science, London and New York. C.J. Brine, P.A. Sanford, J.P. Zikakis (Eds.).
57. Suntornsuk W., Pochanavanich P., Suntornsuk L. Fungal chitosan production on food processing by-products. Proc. Biochem. 2002, 37:727-729.
58. Tai T.S., Sheu W., Lee W.J., Yao H.T., Chiang M.T. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care 2000, 23:1703-1704.
59. Tajdini F., Ali Amini M., Nafissi-Varcheh N., Ali Faramarzi M. Production, physiochemical and antimicrobial properties of fungal chitosan from Rhizomucor miehei and Mucor racemosus. Int. J. Biol. Macromol. 2010, 47:180-183.
60. Takahashi T., Imaia M., Suzukia I., Sawai J. Growth inhibitory effect on bacteria of chitosan membranes regulated by the deacetylation degree. Biochem. Eng. J. 2008, 40:485-491.
61. Tomida H., Fujii T., Furutani N., Michihara A., Yasufuku T., Akasaki K., Maruyama T., Otagiri M., Gebicki J.M., Anraku M. Antioxidant properties of some different molecular weight chitosans. Carbohydr. Polym. 2009, 344:1690-1696.
62. Trautwein E.A., Jurgensen U., Erbersdobler H.F. Cholesterol-lowering and gallstone-preventing action of chitosans with different degrees of deacetylation in hamsters fed cholesterol-rich diets. Nutr. Res. 1997, 17:1053-1065.
63. Uchida Y., Izume M., Ohtakara A. Preparation of chitosan oligomers with purified chitosanase and its application. Chitin and Chitosan 1989, 373-382. Elsevier Applied Science, United Kingdom. G. Skjak-Braek, T. Anthonsen, P. Standford (Eds.).
64. Ueno H., Mori T., Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 2001, 52:105-115.
65. Wang W., Du Y., Qiu Y., Wang X., Hu Y., Yang J., Cai J., Kennedy J.F. A new green technology for direct production of low molecular weight chitosan. Carbohydr. Polym. 2008, 74:127-132.
66. Weiner M.L. An overview of the regulatory status and of the safety of chitin and chitosan as food and pharmaceutical ingredients. Advances in Chitin and Chitosan 1992, 663-670. Elsevier Applied Science, London and New York. C.J. Brine, P.A. Sanford, J.P. Zikakis (Eds.).
67. Xu G., Huang X., Qin L., Wu J., Hu Y. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats. Asia Pac. J. Clin. Nutr. 2007, 16:313-317.
68. Yao H.T., Chiang M.T. Effect of chitosan on plasma lipids, hepatic lipid and fecal bile acid in Hamsters. J. Food Drug Anal. 2006, 14:183-189.
69. Yen M.T., Yang J.H., Mau J.L. Antioxidant properties of chitosan from crab shells. Carbohydr. Polym. 2008, 74:840-844.
70. Ylitalo R., Lehtinen S., Wuolijoki E., Ylitalo P., Lehtimaki T. Cholesterol-lowering properties and safety of chitosan. Arzneimittelforschung 2002, 52:1-7.
71. Zhou K., Xia W., Zhang C., Yu L. In vitro binding of bile acids and triglycerides by selected chitosan preparations and their physicochemical properties. LWT Food Sci. Technol. 2006, 39:1087-1092.